Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Operating Margin (2016 - 2025)

Historic Operating Margin for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to 61.84%.

  • Ironwood Pharmaceuticals' Operating Margin rose 338500.0% to 61.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.34%, marking a year-over-year increase of 101200.0%. This contributed to the annual value of 26.5% for FY2024, which is 2400400.0% up from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Operating Margin stood at 61.84%, which was up 338500.0% from 53.17% recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year Operating Margin high stood at 63.77% for Q4 2022, and its period low was 1008.68% during Q2 2023.
  • Moreover, its 5-year median value for Operating Margin was 51.1% (2021), whereas its average is 14.07%.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Operating Margin crashed by -10659200bps in 2023 and then skyrocketed by 10351400bps in 2024.
  • Ironwood Pharmaceuticals' Operating Margin (Quarter) stood at 48.32% in 2021, then surged by 32bps to 63.77% in 2022, then plummeted by -50bps to 31.98% in 2023, then grew by 9bps to 34.78% in 2024, then soared by 78bps to 61.84% in 2025.
  • Its Operating Margin was 61.84% in Q3 2025, compared to 53.17% in Q2 2025 and 70.75% in Q1 2025.